Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06935214
NA

The Repeatability of the Effect of Caffeine Supplementation on Submaximal Physiological Responses and Cycling Time Trial Performance

Sponsor: St. Mary's University, Twickenham

View on ClinicalTrials.gov

Summary

Recently, Grgic (2018) discussed the concept of responders and non-responders to caffeine supplementation highlighting the importance of the repeatability of results. However, the number of studies that have investigated this idea by repeating the same time-trial performance test multiple times with the same caffeine dose is sparse (Astorino et al., 2012; Del Coso et al., 2019). Furthermore, studies have shown that differences in the CYP1A2 genotype may account for some of the variation in time-trial performance (Guest et al., 2018). Thus, the current study aims to identify whether the effects of moderate caffeine supplementation (5 mg/kg) on time-trial performance are repeatable to aid the identification of responders and non-responders. Additionally, the study aims to determine if the CYP1A2 genotype may explain any of the variability in time-trial performance in trained male cyclists.

Key Details

Gender

MALE

Age Range

18 Years - 35 Years

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2025-05-01

Completion Date

2025-12-31

Last Updated

2025-04-20

Healthy Volunteers

Yes

Conditions

Interventions

DIETARY_SUPPLEMENT

Caffeine

5 mg/kg of caffeine in pill form

DIETARY_SUPPLEMENT

Placebo

5 mg/kg dose of maltodextrin in pill form

DIETARY_SUPPLEMENT

Caffeine

5 mg/kg dose of caffeine in pill form